History International Consultation on Sexual Medicine

COMMITTEE 1; Current definitions, classification and epidemiology of sexual dysfunction in men and women
Chairs: Marita McCabe, Australia, Ira Sharlip, USA
Members: Elham Attalla, Bahrain, Richard Balon, USA, Alessandra Fisher, Italy, Edward Laumann, USA, Sung Won Lee, Korea, Ronald Lewis, USA, Robert Taylor Segraves, USA,
Consultant: Hui Jiang, China

COMMITTEE 2; Psychological and interpersonal dimensions of sexual function and dysfunction in both sexes, ethical and socio-cultural aspects
Chairs: Lori Brotto, Canada, Kevan Wylie, United Kingdom
Members: Carmita Abdo, Brazil, Sandrine Atallah, Lebanon, Sandra Byers, Canada, Cynthia Graham, United Kingdom, Crista Johnson-Agbakwu, USA, Brynjar Fowels Landmark, Norway, Pedro Nobre, Portugal, Talli Rosenbaum, Israel

COMMITTEE 3; Clinical evaluation and symptom scales used in assessment sexual dysfunction in men and women
Chairs: Lorraine Dennerstein, Australia, Dimitrios Hatzichristou, Greece, Raymond Rosen, USA
Members: Linda Banner, USA, Paraskevi-Sofia Kirana, Greece, Risa Lonnee-Hoffmann, Norway, Eric Meuleman, The Netherlands,
Consultant: Mark Hirsch, USA

COMMITTEE 4; Experimental models for the study of women’s and men’s sexual function
Chairs: Petter Hedlund, Sweden, James Pfaus, Canada
Members: Fabio Castiglione, Italy, Pierre Clement, France, Noel Kim, USA, Sae Woong Kim, Korea, Leslie Marson, USA, Gabriella Rodriguez-Manzo, Mexico

COMMITTEE 5; Sexual health and illness
Chairs: Luca Incrocci, The Netherlands, Michael Krychman, USA
Members: David Baldwin, United Kingdom, Nelson Bennett Jr., USA, Ahmed El-Zawahry, USA, Alessandra Graziottin, Italy, Geoff Hackett, United Kingdom, Kevin McVary, USA, Yoshikazu Sato, Japan,
Consultant: Monika Lukasiewicz, Poland

COMMITTEE 6; Future diagnostics and treatment targets for sexual dysfunctions, including stem cell based therapies
Chairs: Irwin Goldstein, USA, Tom Lue, USA
Members: Maarten Albersen, Belgium, George Christ, USA, Yutian Dai, China, Jae-Seung Paick, Korea, Yoram Vardi, Israel, Zhong Cheng Xin, China, Hana Yoon, Korea
Consultant: Melissa Farmer, USA

COMMITTEE 7; Standards for clinical trials in women’s and men’s sexual dysfunction evaluating research designs and outcomes assessment
Chairs: William Fisher, Canada, Lior Lowenstein, Israel
Members: Ilan Gruenwald, Israel, Emmanuele Jannini, Italy, Ahinoam Lev Sagie, Israel, Robert Pyke, USA, Dennis Revicki, USA, Eusebio Rubio-Aurioles, Mexico
Consultant: Yacov Reisman, The Netherlands

COMMITTEE 8; Physiology and pathophysiology of men’s sexual desire, arousal and penile erection
Chairs: Arthur Burnett, USA, Mario Maggi, Italy
Members: Antonio Aversa, Italy, Giovanni Corona, Italy, Kelvin Davies, USA, Ahmed El-Sakka, Egypt, Johanna Hannan, USA, Andrea Isidori, Italy

COMMITTEE 9; Priapism, Peyronie’s disease, penile trauma and reconstructive surgery
Chairs: Gregory Broderick, USA, David Ralph, United Kingdom
Members: Trinity Bivalacqua, USA, Eric Chung, Australia, Giulio Garaffa, United Kingdom, Sidney Glina, Brazil, Lawrence Hakim, USA, Ates Kadioglu, Turkey, Hossein Sadeghi-Nejad, USA, Ahmed Shamsodini, Qatar, Claudio Teloken, Brazil

COMMITTEE 10; Disorders of orgasm and ejaculation in men
Chairs: Juza Chen, Israel, Marcel Waldinger, The Netherlands
Members: Ibrahim Abdel-Hamid, Egypt, Natalio Cruz Navarro, Spain, Bert-Jan de Boer, The Netherlands, Stacy Elliott, Canada, Michael Perelman, USA, Ege Can Serefoglu, Turkey, Eelke Snoeren, Norway

COMMITTEE 11; Implants, mechanical devices and vascular surgery for erectile dysfunction
Chairs: Laurence Levine, USA, Allen Morey, USA,
Members: Edgardo Becher, Argentina, Anthony Bella, Canada, William Brant, USA, Tobias Köhler, USA, Juan Ignacio Martinez Salamanca, Spain, Ricardo Munarriz, USA, Landon Trost, USA, Run Wang, USA

COMMITTEE 12; Pharmacotherapy for erectile dysfunction, testosterone deficiency and sexual rehabilitation after treatment for prostate cancer
Chairs: Mohit Khera, USA, Andrea Salonia, Italy
Members: Jacques Buvat, France, Serge Carrier, Canada, Amr El-Meliegy, Saudi Arabia, Konstantinos Hatzimouratidis, Greece, Andrew McCullough, USA, Abraham Morgentaler, USA, Luiz Otavio Torres, Brazil
Consultant: Ganesan Adaikan, Singapore

COMMITTEE 13; A: The physiology women’s sexual function and pathophysiology of women’s sexual dysfunction
Chair: Roy Levin, United Kingdom
Members: Stephanie Both, The Netherlands, Janniko Georgiadis, The Netherlands, Tuuli Kukkonen, Canada, Kwangsung Park, Korea, Claire Yang, USA

COMMITTEE 13; B: Endocrine aspects of women’s sexual function and dysfunction
Chair: Susan Davis, Australia
Members: Karen Miller, USA, Nanette Santoro, USA, Rosie Worsley, Australia,
Consultant: Leah Millheiser, USA

COMMITTEE 14; Treatment of women’s sexual desire, arousal and orgasmic disorders
Chairs: Sheryl Kingsberg, USA, James Simon, USA
Members: Johannes Bitzer, Switzerland, Andrea Bradford, USA, Joana Carvalho, Portugal, Kathryn Flynn, USA, Rosella Nappi, Italy, Jenny Reese, USA, Leslie Schover, USA, Jan Shifren, USA
Consultants: David Portman, USA, Roya Rezaee, USA

COMMITTEE 15; Women’s sexual pain disorders
Chairs: Andrew Goldstein, USA, Caroline Pukall, Canada
Members: Gloria Bachmann, USA, Sophie Bergeron, Canada, Candace Brown, USA, Catherine Cahill, USA, Christina Damsted Petersen, Denmark, David Foster, USA, Susan Kellogg-Spadt, USA, Amy Stein, USA

COMMITTEE 16; Existing and future educational needs and platforms
Chairs: Eli Coleman, USA, Ian Eardley, United Kingdom
Members: Abdulaziz Baazeem, Saudi Arabia, John Dean, United Kingdom, Sue Goldstein, USA, Yacov Reisman, The Netherlands, Alan Shindel, USA
Consultant: Andrew Kramer, USA

Message of the Chairman

The Third International Consultation on Sexual Medicine (ICSM), which took place on July 10 to July 13, 2009 at the Palais de Congres in Paris, France was organized under the auspices of the International Consultation on Urological Diseases and the International Society for Sexual Medicine (ISSM). This year’s ICSM was a truly memorable scientific event full of impressive discoveries, never before seen studies backed by robust data and an overwhelming interest from the audience. After having watched and listened to each and every one of the presentations given during the four

day meeting, we are pleased to affirm that the field of Sexual Medicine for both Men and Women is making enormous progress. This well deserved success is due to the dedication, perseverance and hard work done by the renowned experts in the field who selflessly devote their time, intellect and energy to promoting the results and findings obtained by their studies.

To successfully carry out a meeting and publication as important as this, careful preparation was necessary. In early 2008, Chairman Francesco Montorsi, Secretary Saad Khoury, Honorary President Tom Lue and Vice Chairs; Ganesan Adaikan, Rosemary Basson, Edgardo Becher, Anita Clayton, Francois Giuliano, Ira Sharlip all met together in person or by phone conference in Paris with the ISSM office representatives to brainstorm on how a reference such as the Recommendations for Sexual Medicine should be developed. Much thought and consideration went into deciding what topics should be considered as chapters and how the meeting and eventual publication would be organized.

Choosing the Chairpersons, Members and Consultants was not an easy task as the experts in these fields are many and each very distinguished. The identification of the members of all the committees started from a very rigorous assessment of the chairpersons and members of the 2003 Consultation as we clearly wanted to have on board again all those who had given a substantial contribution to that meeting and were still available to actively participate this further endeavour.

In addition, a very extensive PubMed search and a thorough evaluation of the scientific programmes of the most important international scientific meetings devoted to sexual medicine served to identify the names of the top experts from the five continents.

The topics that were discussed in the 2003 Consultation served as the basis to build the programme of the 2009 meeting. We considered the advances done in the field during the last six years and we identified all the areas which deserved to be specifically investigated by the experts of the new Consultation. In the end, we were able to produce a table of contents composed of 25 Chapters covering a vast spectrum of the critical topics concerning aspects of sexual medicine for both men and women.

The lists of topics and experts were then matched and the committees were formed. Although a few of those on each of our“wish lists”could not be included due to economic restraints, we were able to guarantee the participation of 186 experts to the final program.

The preparatory meetings held at the various major national meetings, the ISSM in Brussels and the American Urological Association 2009 annual meeting in Chicago, were essential to understand how each chapter was progressing and what the next steps should be. These meetings allowed everyone to finally meet face-to-face under the same roof to streamline ideas and final recommendations of their respective chapters. We were impressed to see the close collaboration the committees had with one another to make sure that ideas were shared without overlap.

The work of the various committees was indeed very hard and was witnessed by the exchange of a huge number of emails aimed at discussing the contents of the various chapters. We are very pleased to inform you that we were always able to touch with our hands the enthusiasm and passion for science shown by the chairs and members of the committees. Sometimes there were strong views which would be contrasting but at the end it was always possible to find a general consensus and the final editing of the chapters text was overall very smooth.

In Paris, the presentations of the committees were really top quality and it was clear to the audience that a huge amount of work was behind the slides that were shown. The discussion sessions were always very lively and many ideas that came out of these were used to improve the final text of the chapters.

In the end, we believe that our objective to create and update a set of standards from evidence based studies and years of research has been reached. This gratifying accomplishment could not have been made without the support from the previously mentioned organizations, the various sponsors and the ambitious staff of the Consultation.

We are grateful to everyone involved and especially to Ira Sharlip who was instrumental in maintaining the necessary geographical balance when identifying the top experts and also in obtaining funding for the meeting; to Tom Lue and all the Vice Chairs who were extremely active during all the preparatory phases and to David Casalod and his team who were the responsible persons for the very efficient logistics.

We are convinced that these contributions will be key in advancing our knowledge in the field of sexual medicine and ultimately in improving the care of our patients.

• FRANCESCO MONTORSI, Chairman, ICSM
• CATHERINE J. PIERCE, Assistant to the Chairman, ICSM
• SAAD KHOURY, Secretary, ICSM 

Committee 1: Historical highlights of sexual dysfunctions in men and women

Sidney Glina, Brazil, Dirk Schultheiss, Germany, Gorm Wagner, Denmark

Committee 2: Definitions, classification and epidemiology of sexual dysfunction

Kerstin Fugl Meyer, Sweden, Ron Lewis, USA, Giovanni Corona, Italy,
William Fisher, Canada, Edward Laumann, USA, Edson Moreira, Brazil,
Alessandra Rellini, Italy, Taylor Segraves, USA, Consultant Dale Glasser, USA

Committee 3: Psychological and interpersonal dimensions of sexual function and dysfunction

Stanley Althof, USA, Marita McCabe, Australia, Pierre Assalian, Canada, Marie Chevret-Measson, France, Sandra Leiblum, USA, Chiara Simonelli, Italy, Kevan Wylie, UK

Committee 4: Ethical, socio-cultural and educational aspects of sexual medicine

John Dean, UK, Khaled Dabees, Egypt, Sharon Parish, USA, Eusebio Rubio-Aurioles, Mexico, Leonore Tiefer, USA, Consultant Fernando Ugarte y Romano, Mexico

Committee 5: Economic aspects of sexual dysfunction

Geoff Hackett, UK, Ridwan Shabsigh, USA, Nicolae Calomfirescu, Romania, Yasusuke Kimoto, Japan, Siegfried Meryn, Austria, Luis Otavio Torres, Brazil,
Consultants Carolyn Earle, Australia, Prithy, Ramlachan, South Africa

Committee 6: Clinical evaluation and symptom scales: sexual dysfunction assessment

Dimitris Hatzichristou, Greece, Raymond Rosen, USA, Leonard Derogatis, USA, Eric Meuleman, Netherlands, Michael O’Leary, USA, Yoram Vardi, Israel, Wah Yun Low, Malaysia, Consultants Mariano Sotomayor De Zava, Mexico, Tara Symonds, UK

Committee 7: Experimental models for the study of female and male sexual function

Francois Giuliano, France, Kim Wallen, USA, Petter Hedlund, Sweden, Leslie Marson, USA, Jim Pfaus, Canada, Balasubramanian Srilatha,Singapore, Consultant Shin-ichi Hisaue, Japan

Committee 8: Cardiovascular aspects of sexual medicine

Graham Jackson, UK, Piero Montorsi, Italy, Michael Adams, Canada, Tarek Anis, Egypt, Ahmed El Sakka, Saudi Arabia, Charalambos Vlachopoulos, Greece, Consultant Edward Kim, USA

Committee 9: Sexual function in chronic illness and cancer

Rosemary Basson, Canada, Luca Incrocci, Netherlands, Michael Krychman, USA, Angel Luis Montejo, Spain, Antonio Martin Morales, Spain, Peter Rees, Canada, Leslie Schover, USA, Run Wang, USA

Committee 10: Sexually transmitted diseases and sexual function

Hossein Sadeghi Nejad, USA, Marlene Wasserman, South Africa, David Goldmeier, UK, Lucia O’Sullivan, Canada, Wolfgang Weidner, Germany

Committee 11: Future treatment targets for sexual dysfunctions

Arthur Burnett, USA, Irwin Goldstein, USA, Karl-Eric Andersson, Sweden, Antonio Argiolas, Italy, George Christ, USA, ZhongCheng Xin, China

Committee 12: Standards for clinical trials in male sexual dysfunctions

Hartmut Porst, Germany, Yoram Vardi, Israel, Emre Akkus, Turkey, Jamie Barada, USA, Serge Carrier, Canada, Arnold Melman, USA, Nam Cheol Park, South Korea, Allen Seftel, USA, Claudio Teloken, Brazil, Mike Wyllie, UK

Committee 13: Physiology and pathophysiology of Men’s Sexual Arousal and Penile Erection

Tom Lue, USA, Christian Stief, Germany, Javier Angulo, Spain, Yutain Dai, China, Noel Kim, USA, Stephan Uckert, Germany, Eric Wespes, Belgium, Consultants Kanchan Chitaley, USA, Jae-Seung Paick, South Korea, Ulf Simonsen, Denmark

Committee 14: Endocrine aspects of male sexual dysfunction

Jacques Buvat, France, Mario Maggi, Italy, Abraham Morgentaler, USA, Claude Schulman, Belgium, Michael Zitzman, Germany, Consultants Andre Guay, USA, Joel M. Kaufman, USA, Hui Meng Tan, Malaysia, Luiz Otavio Torres, Brazil

Committee 15: Priapism

Gregory Broderick, USA, Ates Kadioglu, Turkey, Trinity Bivalacqua, USA, Hussein Ghanem, Egypt, Ajay Nehra, USA, Rany Shamloul, Canada

Committee 16: La Peyronie’s Disease, penile trauma and gender reassignment surgery

Lawrence Levine, USA, David Ralph, UK, Thierry Lebret, France, Vincenzo Mirone, Italy, Michael Sohn, Germany, Consultants Nestor Gonzalez Cadavid, USA, Sava Perovic, Serbia, Mustafa Usta, Turkey

Committee 17: Disorders of orgasm and ejaculation in men

Chris McMahon, Australia, David L. Rowland, USA, Carmita Abdo, Brazil, Juza Chen, Israel, Emmanuele Jannini, Italy, Marcel Waldinger, Netherlands, Consultant Tai Young Ahn, South Korea

Committee 18: Implants, mechanical devices and vascular surgery for erectile dysfunction

Wayne Hellstrom, USA, Karl Montague, USA, Culley Carson, USA, Sudhakar Krishnamurti, India, Suks Minhas, UK, Ignacio Moncada, Spain, Consultant Geraldo Faria, Brazil

Committee 19: Pharmacotherapy for erectile dysfunction

Craig Donatucci, USA, Ian Eardley, UK, Jackie Corbin, USA, Kostas Hatzimouratidis, Greece, Kevin McVary, USA, Consultants Ricardo Munarriz, USA, Sun Won Lee, South Korea

Committee 20: Sexual rehabilitation after treatment for prostate cancer

Gerald Brock, Canada, John Mullhall, USA, Alberto Briganti, Italy, Klaus Peter Juenemann, Germany, Andrew McCullough, USA, Consultants Anthony Bella, Canada, Ray Costabile, USA

Committee 21: Standards for clinical trials in sexual dysfunctions of women: research designs and outcomes assessment

Anita Clayton, USA, Lorraine Dennerstein, Australia, Andre Guay, USA, Sheryl Kingsberg, USA, Michael Perelman, USA

Committee 22: Physiology of women’s sexual function and pathophysiology of women’s sexual dysfunction

Annamaria Giraldi, Denmark, Andrea Salonia, Italy, Meredith Chivers, Canada, Janniko Georgiadis, Netherlands, Ken Maravilla, USA, Margaret McCarthy, USA, Helen O’Connell, Australia, Consultant Roy Levine, USA

Committee 23: Endocrine aspects of women’s sexual dysfunction

Rossella Nappi, Italy, Margaret Wierman, USA, Wiebke Arlt, UK, Nancy Avis, USA, Susan Davis, Australia, Fernand Labrie, Canada, William Rosner, USA, Jan Shifren, USA

Committee 24: Women’s sexual desire and arousal disorders

Lori Brotto, Canada, Johanes Bitzer, Switzerland, Ellen Laan, Netherlands, Sandra Leiblum, USA, Mijal Luria, Israel

Committee 25: Women’s sexual pain disorders

Jacques van Lankveld, Netherlands, Irv M. Binik, Canada, Michal Granot, Israel, Alessandra Graziottin, Italy, Willibrord Weijmar Schultz, Netherlands, Consultants Nina Bohm-Starke, Sweden, Caroline Pukall, Canada, Ursula Wesselmann, USA